(FBSS) |
| 0 (0%) 07-18 18:18 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 134.51 |
| Resistance 1: | 124.62 |
| Pivot price: | 122.67 |
| Support 1: | 108.63 |
| Support 2: | 90.38 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 4.400 |
| Book Value | 23.520 |
| PEG Ratio | 1.77 |
| Gross Profit | 11.144 |
| Profit Margin (%) | 11.56 |
| Operating Margin (%) | 16.02 |
| Return on Assets (ttm) | 11.2 |
| Return on Equity (ttm) | 20.5 |
Company news
Thu, 14 May 2026
Olagbegi promises development, declares for Owo/Ose - The Guardian Nigeria News
Fri, 03 Apr 2026
Faith meets enterprise: Olagbegi’s ‘Owo Praise’ signals rise of local event economy - Business News Nigeria
Thu, 06 Nov 2025
Optimizing FBS 3D positions for sum rate maximization in downlink NOMA 6G network - Nature
Fri, 26 Sep 2025
First report of transient urinary retention after bilateral lumbar ESPB in a patient with FBSS: a case report - Frontiers
Wed, 02 Jul 2025
From Ohio State's WRs to Texas' EDGEs: A college football superteam built from the FBS's best position groups - CBS Sports
Wed, 09 Oct 2024
Comparative Efficacy of Spinal Cord Stimulation in the Management of Acute Pain and Chronic Pain Related to Failed Back Surgery Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials - Cureus
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
